Evidence map›Paper›PMID 19708712›Full record

ArticleThe journal of physical chemistry. B2009

Side chain interactions can impede amyloid fibril growth: replica exchange simulations of Abeta peptide mutant.

Takako Takeda, Dmitri K Klimov

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Globular state in the oligomers formed by Abeta peptides.The Journal of chemical physics · 2010
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Takako TakedaDepartment of Bioinformatics and Computational Biology, George Mason University, Manassas, Virginia 20110, USA.
Dmitri K Klimov
George Mason University · US

Funding

Pathways of Alzehimer's amyloid assembly studied by computer simulationsR01AG028191 · NIA · GEORGE MASON UNIVERSITY · PI KLIMOV, DMITRI KONSTANTINOVICH · 2007 to 2009
$490k
NIA NIH HHS R01 AG028191
6 · The paper itself

Abstract

Using replica exchange molecular dynamics, we study the effect of Asp23Tyr mutation on Abeta(10-40) fibril growth. The effect of this mutation is revealed through the computation of free energy landscapes, the distributions of peptide-fibril interactions, and by comparison with the wild-type Abeta(10-40) peptide. Asp23Tyr mutation has a relatively minor influence on the docking of Abeta peptides to the fibril. However, it has a strong impact on the locking stage due to profound stabilization of the parallel in-registry beta-sheets formed by the peptides on the fibril edge. The enhanced stability of parallel beta-sheets results from the deletion of side chain interactions formed by Asp23, which are incompatible with the fibril-like conformers. Consequently, Asp23Tyr mutation is expected to promote fibril growth. We argue that strong off-registry side chain interactions may slow down fibril assembly as it occurs for the wild-type Abeta peptide. The analysis of experimental data offers support to our in silico conclusions.

Indexed as

MutationAmino Acid SequenceAmyloid beta-PeptidesAspartic AcidComputer SimulationHumansMagnetic Resonance SpectroscopyModels, BiologicalMolecular ConformationMolecular Sequence DataPeptidesProtein Structure, SecondarySolventsThermodynamicsTyrosineAmyloid beta-PeptidesAspartic AcidPeptidesSolventsTyrosine

Identifiers

PMID19708712
PMCPMC2765228
OpenAlexW2080188490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.